Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859780 · ClinicalTrials.gov registry record · NA
Visual Distraction as a Means of Enhancing Child Resistance
A NA study of Unintentional Ingestion of Prescriptions Within Vials and Blisters, sponsored by Michigan State University.
- Completed
- Registry status
- NA
- Development phase
- 229
- Enrollment target
- 3
- Study locations
NCT01859780 is a NA study of Unintentional Ingestion of Prescriptions Within Vials and Blisters that has completed, run by Michigan State University. The registered enrollment target is 229 participants. The trial reports 3 study locations across 2 states.
The verdict
NCT01859780, a NA study of Unintentional Ingestion of Prescriptions Within Vials and Blisters, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 229 participants
- Enrollment target
- 3
- Study locations
Study Summary
Unintentional poisonings of children continues to be a major issue in the US. According to a study conducted by Cincinnati Children's Hospital Medical Centers, during the period from 2001-2008, emergency room visits for children less than 5 rose 28% as the result of pharmaceutical products. The authors note, "the problem of pediatric medication poisoning is getting worse, not better." Child resistant closures have been required on most medications sold in the US since the early 1970s. However, most designs attempt to thwart children through purely physical means (e.g. simultaneous dissimilar motion or opening using sequential tasks). Few, if any designs, have utilized perception and cognition as a way to enhance child resistance. The investigators propose utilizing visual illusions in spaces distinct from the opening mechanism of prescription packages as a means of enhancing child resistance. In this project, visual illusion images are applied to both vials and wallet blisters in order to attract children's interest and prolong the time before opening. During Stage I, the investigators will determine if the visual distractor attracts attention when samples are displayed in a storage rack. During Stage II, the investigators will test the effect of visual distractors on child resistance as measured by successful openings and time to open.
Conditions Studied
Interventions
- OTHER Visual distractor
Study Locations (3)
Michigan
- Packaging Building - East Lansing
- LESA Early Childhood Programs - Howell
Ohio
- Great Lakes Marketing - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01859780
The ClinicalTrials.gov registry entry for NCT01859780 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Unintentional Ingestion of Prescriptions Within Vials and Blisters appearing as the primary indexed condition, and to 1 intervention - of which Visual distractor is the first listed.
NCT01859780 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Ohio.
Frequently Asked Questions
What is clinical trial NCT01859780 about?
NCT01859780 is a clinical study titled "Visual Distraction as a Means of Enhancing Child Resistance". Unintentional poisonings of children continues to be a major issue in the US. According to a study conducted by Cincinnati Children's Hospital Medical Centers, during the period from 2001-2008, emergency room visits for children less than 5 rose 28% as the result of pharmaceutical products. The auth...
What is the current status of trial NCT01859780?
This trial is currently completed. It is a NA study. The enrollment target is 229 participants. The study started on 2013-08. Estimated completion is 2015-04.
What conditions does trial NCT01859780 study?
This clinical trial studies the following conditions: Unintentional Ingestion of Prescriptions Within Vials and Blisters.
What interventions are being tested in trial NCT01859780?
The interventions under investigation include: Visual distractor (OTHER).
Who is sponsoring clinical trial NCT01859780?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01859780 being conducted?
This trial has 3 study locations across Michigan, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.